AHMFX | PTFRX | AHMFX / PTFRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 7 years | - |
Gain YTD | 0.719 | 0.601 | 120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.9B | 677M | 1,905% |
Annual Yield % from dividends | 4.02 | 3.90 | 103% |
Returns for 1 year | 3.11 | 2.00 | 155% |
Returns for 3 years | -4.55 | -6.91 | 66% |
Returns for 5 years | -5.77 | -10.06 | 57% |
Returns for 10 years | 3.62 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTTX | 25.15 | -0.04 | -0.16% |
Fidelity Advisor Biotechnology M | |||
CLSYX | 19.87 | -0.07 | -0.35% |
Columbia International Div Inc Inst3 | |||
WASIX | 11.91 | -0.10 | -0.83% |
Seven Canyons Strategic Global Investor | |||
VGRIX | 80.74 | -1.07 | -1.31% |
JPMorgan US Value A | |||
JSMTX | 18.13 | -0.44 | -2.37% |
Jackson Square SMID-Cap Growth Instl |